Temozolomide for Injection

Temozolomide for Injection
Product Description

It is an oral chemotherapy drug. It is analkylating agent used as a treatment of some brain cancers; as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma multiforme.

Strength: 100mg

It has been approved by CFDA.

Jiangsu Hengrui Medicine Co., Ltd.

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Manufacturer/Innovator

Jiangsu Hengrui Medicine Co., Ltd.

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Manufacturer/Innovator

More Products from Jiangsu Hengrui Medicine Co., Ltd. (99)

  • Paliperidone Palmitate Extended-Release Injectable Suspension

    Product Paliperidone Palmitate Extended-Release Injectable Suspension

    Paliperidone Palmitate Extended-Release Injectable Suspension is a kind of antipsychotic drugs.

    Strength: 25mg/0.25ml; 50mg/0.5ml; 75mg/0.75ml; 100mg/mL; 150mg/1.5ml (on basis of Paliperidone)

    It is in R&D stage.

    Dossiers are in preparation for US-FDA and EU appro...
  • Tacrolimus, Capsule, Extended Release

    Product Tacrolimus, Capsule, Extended Release

    Tacrolimus is an immunosuppressive drug used mainly after allogeneic organ transplant to lower the risk of organrejection. It achieves this by inhibiting the production of interleukin-2, a molecule that promotes the development and proliferation of T cells,...
  • Trabectedin for Injection

    Product Trabectedin for Injection

    Trabectedin for Injection is an anti-tumor chemotherapy drug. 

    Strength: 0.25mg; 1mg

    US-ANDA in preparation.Dossiers for EU market approval: in preparation.

  • Apatinib Mesylate Tablets

    Product Apatinib Mesylate Tablets

    It is an orally bioavailable, small-molecule receptor tyrosine kinase inhibitor.

    Strength: 0.25g; 0.375g; 0.425g

    NMPA approved.

  • Pegaspargase Injection

    Product Pegaspargase Injection

    It is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase which has undergone PEGylation. It is used in the treatment of acute lymphoblastic leukemia.

    Strength: 5ml:3750IU; 2ml:1500IU

    It has...
  • Tegafur, Gimeracil, Oteracil Potassium Capsules

    Product Tegafur, Gimeracil, Oteracil Potassium Capsules

    It is used for the treatment of advanced gastric cancer.

    Strength: 

    Tegafur: 20mg, Gimeracil: 5.8mg, Oteracil potassium: 19.6mg;

    Tegafur: 25mg, Gimeracil: 7.25mg, Oteracil potassium: 24.5mg

    It has been approved by NMPA.

  • Zoledronic Acid for Injection

    Product Zoledronic Acid for Injection

    It is a bisphosphonate drug given intravenously to treat some bone diseases. It is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer, as well as for treating osteoporosis....
  • Bupivacaine Liposome Injectable Suspension

    Product Bupivacaine Liposome Injectable Suspension

    It is indicated for local infiltration, peripheral nerve block, sympathetic nerve block, andepidural and caudal blocks. It is sometimes used in combination with epinephrine to prevent systemic absorption and extend the duration of action.

    Strength: 133mg/10ml...
  • Eribulin Mesylate Injection

    Product Eribulin Mesylate Injection

    Eribulin Mesylate Injection is used to treat certain patients with breast cancer and liposarcoma.

    Strength: 1mg/2ml

    This product is still in R & D stage.
  • Gadobutrol Injection

    Product Gadobutrol Injection

    Gadobutrol Injection is a gadolinium-based MRI contrast agent (GBCA).

    Strength: (604.72mg/ml) *2ml  *7.5ml  *10ml  *15ml  *30ml  *65ml

    This product is still in R & D stage.

  • Gadobenate Dimeglumine injection

    Product Gadobenate Dimeglumine injection

    This is a kind of contrast media. 
    Strength:  (529mg/ml) *5ml  *10ml  *15ml  *20ml

    It is still in R&D stage.
  • Iohexol Injection

    Product Iohexol Injection

    Iohexol is a kind of contrast media.

    Strength: to be determined.

    This product is still in R&D stage.

Jiangsu Hengrui Medicine Co., Ltd. resources (1)